Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 56, Issue 5, 2007, Pages 656-661

  Hirota, Yushi ^a   Ohara, Takeshi ^a   Zenibayashi, Masako ^a   Kuno, Shin ichi ^a,b   Fukuyama, Keiko ^a   Teranishi, Tetsuya ^a   Kouyama, Kunichi ^a   Miyake, Kazuaki ^a   Maeda, Eiichi ^a   Kasuga, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE 1 A; ENZYME; LIPID; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ASIAN; CARNITINE PALMITOYLTRANSFERASE 1 A GENE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; HAPLOTYPE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTRON; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CARNITINE O-PALMITOYLTRANSFERASE; DIABETES MELLITUS, TYPE 2; DNA; FATTY LIVER; FEMALE; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; JAPAN; LINKAGE DISEQUILIBRIUM; LIPID METABOLISM; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 34147098356     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.12.014     Document Type: Article

References (32)

1. Almind K., Doria A., and Kahn C.R. Putting the genes for type II diabetes on the map. Nat Med 7 (2001) 277-279
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
3. Maeda K., Ishihara K., Miyake K., et al. Inverse correlation between serum adiponectin concentration and hepatic lipid content in Japanese with type 2 diabetes. Metabolism 54 (2005) 775-780
4. Banerji M.A., Buckley M.C., Chaiken R.L., et al. Liver fat, serum trglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 19 (1995) 846-850
5. Seppala-Lindroos A., Vehkavaara S., Hakkinen A.M., et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87 (2002) 3023-3028
6. Marchesini G., Brizi M., Bianchi G., et al. Nonalcoholic fatty liver disease. A feature of metabolic syndrome. Diabetes 50 (2001) 1844-1850
7. Kelley D.E., McKolanis T.M., Hegazi R.A., et al. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285 (2003) 906-916
8. Petersen K.F., Dufour S., Befroy D., et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54 (2005) 603-608
9. McGarry J.D., Mannaerts G.P., and Foster D.W. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 60 (1977) 265-270
10. McGarry J.D., and Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244 (1997) 1-14
11. Fraser F., Corstorphine C.G., and Zammit V.A. Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane. Biochem J 323 (1997) 711-718
12. Britton C.H., Schultz R.A., Zhang B., et al. Human liver mitochondrial carnitine palmitoyltransferase I: characterization of its cDNA and chromosomal localization and partial analysis of the gene. Proc Natl Acad Sci U S A 92 (1995) 1984-1988
13. Yamazaki N., Shinohara Y., Shima A., et al. Isolation and characterization of cDNA and genomic clones encoding human muscle type carnitine palmitoyltransferase. Biochim Biophys Acta 1307 (1996) 157-161
14. Price N., van der Leij F., Jackson V., et al. A novel brain-expressed protein related to carnitine palmitoyltransferase I. Genomics 80 (2002) 433-442
15. Gobin S., Bonnefont J.P., Prip-Buus C., et al. Organization of the human liver carnitine palmitoyltransferase 1 gene (CPT1A) and identification of novel mutations in hypoketotic hypoglycaemia. Hum Genet 111 (2002) 179-189
16. Bennett M.J., Boriack R.L., Narayan S., et al. Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency. Mol Genet Metab 82 (2004) 59-63
17. Ijlst L., Mandel H., Oostheim W., et al. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency. J Clin Invest 102 (1998) 527-531
18. Brown N.F., Mullur R.S., Subramanian I., et al. Molecular characterization of L-CPT I deficiency in six patients: insights into function of the native enzyme. J Lipid Res 42 (2001) 1134-1142
19. Ogawa E., Kanazawa M., Yamamoto S., et al. Expression analysis of two mutations in carnitine palmitoyltransferase IA deficiency. J Hum Genet 47 (2002) 342-347
20. Sim K.G., Hammond J., and Wilcken B. Strategies for the diagnosis of mitochondrial fatty acid β-oxidation disorders. Clin Chim Acta 323 (2002) 37-58
21. McGarry J.D. Banting Lecture 2001. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
22. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
23. Kawamitsu H., Kaji Y., Ohara T., et al. Feasibility of quantitative intrahepatic lipid imaging applied to the magnetic resonance dual gradient echo sequence. Magn Reson Med Sci 2 (2003) 47-50
24. Johnson G.C., Esposito L., Barratt B.J., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 29 (2001) 233-237
25. Zhang K., Calabrese P., Nordborg M., et al. Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet 71 (2002) 1386-1394
26. Morris R.W., and Kaplan N.L. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 23 (2002) 221-233
27. Bougneres P. Genetics of obesity and type 2 diabetes: tracking pathogenic traits during the predisease period. Diabetes 51 (2002) S295-S303
28. Fukuyama K., Ohara T., Hirota Y., et al. Association of the -112A>C polymorphism of the uncoupling protein 1 gene with insulin resistance in Japanese individuals with type 2 diabetes. Biochem Biophys Res Commun 339 (2006) 1212-1216
29. Stefan N., Machicao F., Staiger H., et al. Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48 (2005) 2282-2291
30. Stefan N., Schafer S., Machicao F., et al. Liver fat and insulin resistance are independently associated with the -514C>T polymorphism of the hepatic lipase gene. J Clin Endocrinol Metab 90 (2005) 4238-4243
31. Pessayre D., Mansouri A., and Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 282 (2002) G193-G199
32. Nyman L.R., Cox K.B., Hoppel C.L., et al. Homozygous carnitine palmitoyltransferase 1a (liver isoform) deficiency is lethal in the mouse. Mol Genet Metab 86 (2005) 179-187